Global Clostridium Difficile Infection Treatment Market Size, Status and Forecast 2020-2026

Clostridium difficile is one of the most common hospital acquired infections and in the last decade, there has been a notable increase in the incidence of clostridium difficile infection as well as the severity of the infection owing to recurrence and antibiotic resistance. Disproportionately higher incidence is seen in patients undergoing a long-term antibiotic treatment such as in patients with diseases like COPD and urinary tract infection. A rising prevalence of these diseases would subsequently accelerate the growth of the global clostridium difficile infection treatment market.
Clostridium difficile infection treatment usually occurs when people have taken antibiotics for a long period of time that change the normal colon bacteria allowing the clostridium difficile bacteria to grow and produce its toxins. High CDI risk antibiotics are clindamycin, cephalosporins, and quinolones including ciprofloxacin and levofloxacin. Increasing use of these antibiotics and antimicrobials is driving the incidence of clostridium difficile infection and is likely to drive the global clostridium difficile infection treatment market over the forecast period.

Market Analysis and Insights: Global Clostridium Difficile Infection Treatment Market
The global Clostridium Difficile Infection Treatment market size is projected to reach US$ 742.2 million by 2026, from US$ 698.6 million in 2020, at a CAGR of 5.8%% during 2021-2026.

Global Clostridium Difficile Infection Treatment Scope and Market Size
Clostridium Difficile Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Clostridium Difficile Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Merck
Baxter International
Sanofi
Pfizer
Novartis
Astellas Pharma
Eli Lilly
AstraZeneca
Actelion Pharmaceuticals
Mylan

Market segment by Type, the product can be split into

Oral
Injectable

Market segment by Application, split into

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India

Frequently Asked Questions